pSivida commences human trials of cancer treatment

Perth-based nanotechnology company pSivida Ltd has announced the first human trial of their pancreatic cancer treatment BrachySil, the first step in a six-month clinical study.


(existing subscribers)

The password field is case sensitive.
Request new password

Add your comment

BNIQ sponsored byNorth Metro TAFE


6th-Australian Institute of Management WA20,000
7th-Murdoch University16,584
8th-South Regional TAFE10,549
9th-Central Regional TAFE10,000
51 tertiary education & training providers ranked by total number of students in WA

Number of Employees

BNiQ Disclaimer